We value your privacy

We use necessary cookies to make this site work, and Google Analytics to measure visits (it sets cookies and is not affected by the choices below). With your consent, we also use our own analytics cookies to understand how the site is used and improve it. Privacy policy

XOOBAY 数贝环球
金盒集团
金盒集团

金盒集团

Premier Elite

5
Products
0
Followers
2013
Established

Wheelchair manufacturer ZJYL officially listed on the NASDAQ on the 28th

Wheelchair manufacturer ZJYL officially listed on the NASDAQ on the 28th

 026be31f8cfc0ba6a3e5ecc54e5c6cd0_mePoX55VEnAAAAABJRU5ErkJggg==.png

On March 28 local time, wheelchair manufacturer Zhongjin Medical officially listed on the NASDAQ with the stock code ZJYL. As of the closing price on the 29th, it was $7.934, with a total market capitalization of $63 million.

The offering price of Zhongjin Medical in this IPO was $8, with 1 million shares issued (originally planned to issue 1.25 million shares), raising $8 million. According to the prospectus, the company plans to use the raised funds for R&D activities, including expanding the R&D team, improving the engineering design of existing products and developing new products; promotion and marketing activities, such as the development, operation and marketing of the company's online platform; expanding production capacity, including expanding and upgrading production lines and facilities; acquiring upstream and downstream companies that manufacture wheelchairs and daily living assistance products, as well as general corporate purposes.

Founded in 2006, Zhongjin Medical is headquartered in Changzhou, Jiangsu, with its main business focusing on the R&D and manufacturing of high-end rehabilitation equipment. Its products cover walking aids, respiratory medical equipment, intelligent nano bathing equipment, as well as the LeYu series products dedicated to the elderly and patients, fitness equipment for the elderly and special groups, and disaster relief and emergency rescue products. The company's products are distributed in more than 100 countries and regions including Japan, the United States, and the European Union.

In the 2021-2022 fiscal year (as of September 30), Zhongjin Medical's revenue was $20.74 million and $19.19 million respectively, with corresponding net profits of $2.63 million and $2.71 million during the same period.

Before the IPO, Wang Erqi, chairman of Zhongjin Medical, held 87.44% of the shares, Gorgeous Abundant Enterprises Limited held 8.59%, and Er Pu International Limited held 8.7%.

After the IPO, Wang Erqi, chairman of Zhongjin Medical, held 73.78% of the shares, Gorgeous Abundant Enterprises Limited held 7.25%, and Er Pu International Limited held 7.34%.

Originally published on 金盒企业管理集团